Novavax is moving one step closer to adding another coronavirus vaccine to the arsenal for health officials in the United States.
The vaccine company is starting Phase Three trial of their COVID-19 vaccine in the US and Mexico. This is the fifth company to launch a large scale trial of a coronavirus vaccine in the United States.
They will have 30-thousand volunteers to try out the vaccine, and the trial is receiving funding from Operation Warp Speed. The company says they aim to make the study diverse to cover the hardest hit segments of the US population. Novavax has its headquarters in Gaithersburg, Maryland.
Source: Wall Street Journal